Be in the know. 18 key reads for Wednesday…

  1. Northrop and Lockheed win missile defense contracts valued at up to $7.6 billion (StreetInsider)
  2. Pfizer Will Test a Pill to Kill the Covid-19 Virus (Barron’s)
  3. Pfizer Goes It Alone to Expand Vaccine Business Beyond Covid-19 Pandemic (Wall Street Journal)
  4. The new S&P 500 bull market is about to enter its second year. Now what? (MarketWatch)
  5. Powell and Yellen’s game plan is evocative of the World War II playbook. Here’s what happened then. (MarketWatch)
  6. Convertible Bonds Are Booming. Here’s What You Need to Know. (Barron’s)
  7. Regeneron Stock Climbs on Positive Covid-19 Antibody Data (Barron’s)
  8. Citigroup and 5 More Lenders Poised for Gains in ‘Bank Renaissance’ (Barron’s)
  9. 5 Beaten-Down Renewable Energy Stocks That May Be Worth a Look (Barron’s)
  10. Intel’s New CEO Is Spending $20 Billion to Double Down on Chip Manufacturing (Barron’s)
  11. Powell Says Stimulus Package Isn’t Likely to Fuel Unwelcome Inflation (Wall Street Journal)
  12. New York Business Leaders Urge State Lawmakers to Not Raise Taxes (Wall Street Journal)
  13. Fed’s Bullard won’t forecast any interest-rate hikes until he sees proof of strong economy (MarketWatch)
  14. Bostic expects Fed to lift rates in 2023 – WSJ (Reuters)
  15. Hawaii gets tourism surge as coronavirus rules loosen up (Fox Business)
  16. Coronavirus latest: Merkel reverses course on Easter lockdown in Germany (Financial Times)
  17. BofA Raises Price Targets for US Banks on Faster-Than-Expected Recovery (StreetInsider)
  18. Banks stand firm on calls for oil ‘supercycle’ even as price drops (Financial Times)